Cargando…

Aptamer–drug conjugate: targeted delivery of doxorubicin in a HER3 aptamer-functionalized liposomal delivery system reduces cardiotoxicity

INTRODUCTION: The toxic side effects of doxorubicin (DOX) have limited its use in chemotherapy. Neither liposomal DOX nor pegylated liposomal DOX are able to completely resolve this issue. This is a proof-of-concept study testing aptamer-drug conjugate (ApDC) targeted delivery systems for chemothera...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dou, Xiao-qian, Wang, Hua, Zhang, Jing, Wang, Fang, Xu, Gui-li, Xu, Cheng-cheng, Xu, Huan-hua, Xiang, Shen-si, Fu, Jie, Song, Hai-feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5804143/ https://www.ncbi.nlm.nih.gov/pubmed/29440899 http://dx.doi.org/10.2147/IJN.S149887

Ejemplares similares

Aptamer-Aptamer Chimera for Targeted Delivery and ATP-Responsive Release of Doxorubicin into Cancer Cells
por: Esawi, Ezaldeen, et al.
Publicado: (2021)

PrP(C) Aptamer Conjugated–Gold Nanoparticles for Targeted Delivery of Doxorubicin to Colorectal Cancer Cells
por: Go, Gyeongyun, et al.
Publicado: (2021)

Using modified aptamers for site specific protein–aptamer conjugations
por: Wang, Ruowen, et al.
Publicado: (2016)

Automated Modular Synthesis of Aptamer–Drug Conjugates for Targeted Drug Delivery
por: Wang, RuoWen, et al.
Publicado: (2014)

Aptamers for Targeted Drug Delivery
por: Ray, Partha, et al.
Publicado: (2010)

Aptamer-targeted Antigen Delivery
por: Wengerter, Brian C, et al.
Publicado: (2014)

Targeted delivery of doxorubicin and therapeutic FOXM1 aptamer to tumor cells using gold nanoparticles modified with AS1411 and ATP aptamers
por: Abdollahzade, Aref, et al.
Publicado: (2023)

Second-generation aptamer-conjugated PSMA-targeted delivery system for prostate cancer therapy
por: Wu, Xin, et al.
Publicado: (2011)

Inhibition of Autophagy Promotes the Elimination of Liver Cancer Stem Cells by CD133 Aptamer-Targeted Delivery of Doxorubicin
por: Yin, Wang, et al.
Publicado: (2022)

Target-specific delivery of doxorubicin to retinoblastoma using epithelial cell adhesion molecule aptamer
por: Subramanian, Nithya, et al.
Publicado: (2012)

Selection of a novel CD19 aptamer for targeted delivery of doxorubicin to lymphoma cells
por: Hu, Yan, et al.
Publicado: (2018)

Doxorubicin-Conjugated Innovative 16-mer DNA Aptamer-Based Annexin A1 Targeted Anti-Cancer Drug Delivery
por: Bavi, Rohit, et al.
Publicado: (2020)

Aptamer mediated siRNA delivery
por: Chu, Ted C., et al.
Publicado: (2006)

Transforming doxorubicin into a cancer stem cell killer via EpCAM aptamer-mediated delivery
por: Xiang, Dongxi, et al.
Publicado: (2017)

Aptamer-Functionalized Nanoparticles in Targeted Delivery and Cancer Therapy
por: Fu, Zhaoying, et al.
Publicado: (2020)

Aptamer-functionalized pH-sensitive liposomes for a selective delivery of echinomycin into cancer cells
por: Lafi, Zainab, et al.
Publicado: (2021)

Aptamer-Gated Nanoparticles for Smart Drug Delivery
por: Ozalp, Veli Cengiz, et al.
Publicado: (2011)

Aptamer-Mediated Targeted Delivery of Therapeutics: An Update
por: Catuogno, Silvia, et al.
Publicado: (2016)

Aptamer-Targeted DNA Nanostructures for Therapeutic Delivery
por: Charoenphol, Phapanin, et al.
Publicado: (2014)

Aptamer Chimeras for Therapeutic Delivery: The Challenging Perspectives
por: Esposito, Carla Lucia, et al.
Publicado: (2018)

Targeting breast cancer stem cells by a self-assembled, aptamer-conjugated DNA nanotrain with preloading doxorubicin
por: Xu, Zhiyuan, et al.
Publicado: (2019)

Development of HER2-Specific Aptamer-Drug Conjugate for Breast Cancer Therapy
por: Jeong, Hwa Yeon, et al.
Publicado: (2020)

Targeted delivery of CRISPR/Cas9 to prostate cancer by modified gRNA using a flexible aptamer-cationic liposome
por: Zhen, Shuai, et al.
Publicado: (2016)

Doxorubicin Loaded DNA Aptamer Linked Myristilated Chitosan Nanogel for Targeted Drug Delivery to Prostate Cancer
por: Atabi, Fereshteh, et al.
Publicado: (2017)

Aptamer-functionalized Hybrid Nanoparticles to Enhance the Delivery of Doxorubicin into Breast Cancer Cells by Silencing P-glycoprotein
por: Chandra, Sruti, et al.
Publicado: (2020)

Aptamer Functionalized Upconversion Nanotheranostic Agent With Nuclear Targeting as the Highly Localized Drug-Delivery System of Doxorubicin
por: Song, Xinyue, et al.
Publicado: (2021)

Non-Invasive Delivery of Therapeutics into the Brain: The Potential of Aptamers for Targeted Delivery
por: Bukari, Bakhtiar, et al.
Publicado: (2020)

Aptamer‐conjugated mesoporous polydopamine for docetaxel targeted delivery and synergistic photothermal therapy of prostate cancer
por: Dai, Liang, et al.
Publicado: (2021)

Artificial Base-Directed In Vivo Formulation of Aptamer–Drug Conjugates with Albumin for Long Circulation and Targeted Delivery
por: Sun, Yang, et al.
Publicado: (2022)

A replaceable liposomal aptamer for the ultrasensitive and rapid detection of biotin
por: Sung, Tzu-Cheng, et al.
Publicado: (2016)

Aptamers as Smart Ligands for Targeted Drug Delivery in Cancer Therapy
por: Wei, Zongyi, et al.
Publicado: (2022)

Delivery of chemo-sensitizing siRNAs to HER2(+)-breast cancer cells using RNA aptamers
por: Thiel, Kristina W., et al.
Publicado: (2012)

Chimeric aptamers in cancer cell-targeted drug delivery
por: Kanwar, Jagat R, et al.
Publicado: (2011)

Aptamer-Targeted Drug Delivery for Staphylococcus aureus Biofilm
por: Ommen, Pernille, et al.
Publicado: (2022)

Aptamer-based nanotrains and nanoflowers as quinine delivery systems
por: Cao, Mengyuan, et al.
Publicado: (2023)

Mucin-1 aptamer-armed superparamagnetic iron oxide nanoparticles for targeted delivery of doxorubicin to breast cancer cells
por: Aghanejad, Ayuob, et al.
Publicado: (2018)

Selection of a novel DNA aptamer against OFA/iLRP for targeted delivery of doxorubicin to AML cells
por: An, Yacong, et al.
Publicado: (2019)

Anti-Epcam Aptamer (Syl3c)-Functionalized Liposome for Targeted Delivery Of Doxorubicin: In Vitro And In Vivo Antitumor Studies in Mice Bearing C26 Colon Carcinoma
por: Mashreghi, Mohammad, et al.
Publicado: (2020)

Insights into Aptamer–Drug Delivery Systems against Prostate Cancer
por: Wang, Xueni, et al.
Publicado: (2022)

Aptamer–Gemcitabine Conjugates with Enzymatically Cleavable Linker for Targeted Delivery and Intracellular Drug Release in Cancer Cells
por: Qi, Jianjun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1phm3944qtp9ci936t5b2m97q7